By analyzing the growth of iCD34+ cells in serum-free medium with growth factors, we found an enhanced expansion of iCD34+CD38− cells from CML iPSCs relative to similar cells from normal BM iPSCs. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.